Differential effects of vitamin D treatment on inflammatory and non-inflammatory breast cancer cell lines

Clinical and Experimental Metastasis

Volumn 29, Issue 8, 2012, Pages 971-979

  Hillyer, Rebecca L ^a   Sirinvasin, Padma ^a   Joglekar, Madhura ^a   Sikes, Robert A ^a   Van Golen, Kenneth L ^a   Nohe, Anja ^a  

^a UNIVERSITY OF DELAWARE   (United States)

Author keywords

Calcitriol; Inflammatory breast cancer; Invasion; MDA MB 231; Migration; SUM149; Tumor emboli; Vitamin D; Vitamin D receptor

Indexed keywords

CALCITRIOL; VITAMIN D RECEPTOR; CALCITRIOL RECEPTOR;

ARTICLE; BREAST CANCER; CANCER CELL; CANCER CELL CULTURE; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DRUG EXPOSURE; FEMALE; HUMAN; HUMAN CELL; INFLAMMATORY BREAST CANCER; MDA MB 231 CELL LINE; METASTASIS; PHENOTYPE; PROTEIN SYNTHESIS; SPHEROID CELL; SUM149 IBC CELL LINE; TUMOR VOLUME; BREAST TUMOR; CANCER INVASION; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PATHOLOGY; TUMOR CELL LINE;

BREAST NEOPLASMS; CALCITRIOL; CELL LINE, TUMOR; CELL PROLIFERATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INFLAMMATORY BREAST NEOPLASMS; NEOPLASM INVASIVENESS; RECEPTORS, CALCITRIOL;

EID: 84872852917     PISSN: 02620898     EISSN: 15737276     Source Type: Journal    
DOI: 10.1007/s10585-012-9486-0     Document Type: Article

References (23)

1. Kleer C, Golen Kv, Merajver S (2000) Molecular biology of breast cancer metastasis. Inflammatory breast cancer: clinical syndrome and molecular determinants. Breast Cancer Res 2(6):423-429
2. Robertson FM, Bondy M, Yang W, et al. Inflammatory breast cancer: the disease, the biology, the treatment. CA Cancer J Clin; 60 (6): 351-75
3. van Golen KL (2003) Inflammatory breast cancer: relationship between growth factor signaling and motility in aggressive cancers. Breast Cancer Res 5(3):174-179
4. Radunsky GS, van Golen KL (2005) The current understanding of the molecular determinants of inflammatory breast cancer metastasis. Clin Exp Metastasis 22(8):615-620
5. Jaiyesimi I, Buzdar A, Hortobagyi G (1992) Inflammatory breast cancer: A review. J Clin Oncol 10(6):1014-1024
6. Dawood S, Merajver SD, Viens P et al (2011) International expert panel on inflammatory breast cancer: consensus statement for standardized diagnosis and treatment. Ann Oncol 22(3):515-523
7. Dawood S, Ueno NT, Valero V, et al. (2012) Identifying factors that impact survival among women with inflammatory breast cancer. Ann Oncol 23(4):870-875
8. Cranney A, Horsley T, O'Donnell S et al (2007) Effectiveness and safety of vitamin D in relation to bone health. Evidence Report/Technology Assessment 158:1-235
9. Krishnan AV, Feldman D (2011) Mechanisms of the anti-cancer and anti-inflammatory actions of vitamin D. Annu Rev Pharmacol Toxicol 51:311-336
10. Krishnan AV, Trump DL, Johnson CS et al (2010) The role of vitamin D in cancer prevention and treatment. Endocrinol Metab Clin North Am 39(2):401-418
11. Vanoirbeek E, Krishnan A, Eelen G et al (2011) The anti-cancer and anti-inflammatory actions of 1,25(OH)D. Best Pract Res Clin Endocrinol Metab 25(4):593-604
12. 3 suppresses cell growth, DNA synthesis, and phosphorylation of retinoblastoma protein in a breast cancer cell line. Cancer Invest 13:280-286
13. Welsh J, Simboli-Campbell M, Narvaez CJ et al (1995) Role of apoptosis in the growth inhibitory effects of vitamin D in MCF-7 cells. Adv Exp Med Biol 375:45-52
14. 3 and its analogues on induction of apoptosis in breast cancer cells. J Steroid Biochem Mol Biol 58:395-401
15. Vink-van Wijngaarden T, Pols HA, Buurman CJ et al (1996) Inhibition of insulin- and insulin-like growth factor-I-stimulated growth of human breast cancer cells by 1,25-dihydroxyvitamin D3 and the vitamin D3 analogue EB1089. Eur J Cancer 32A(5):842-848
16. Xie S, James S, Colston K (1997) Vitamin D derivatives inhibit the mitogenic effects of IGF-I on MCF-7 human breast cancer cells. J Endocrinol 154:495-504
17. Beer TM, Myrthue A (2004) Calcitriol in cancer treatment: from the lab to the clinic. Mol Cancer Ther 3(3):373-381
18. Krishnan AV, Moreno J, Nonn L et al (2007) Calcitriol as a chemopreventive and therapeutic agent in prostate cancer: role of anti-inflammatory activity. J Bone Miner Res 22(Suppl 2):V74-V80
19. Van den Eynden GG, Van Laere SJ, Van der Auwera I et al (2006) Overexpression of caveolin-1 and -2 in cell lines and in human samples of inflammatory breast cancer. Breast Cancer Res Treat 95(3):219-228
20. Van Laere SJ, Van den Eynden GG, Van der Auwera I et al (2006) Identification of cell-of-origin breast tumor subtypes in inflammatory breast cancer by gene expression profiling. Breast Cancer Res Treat 95(3):243-255
21. Buras RR, Schumaker L, Davoodi F et al (1994) Vitamin D receptors in breast cancer cells. Breast Cancer Res Treat 31(2-3):191-202
22. 3 inhibits the invasive potential of human breast cancer cells in vitro. Clin Exp Metastasis 12(3):195-202
23. Hathcock J (1986) Quantitative evaluation of vitamin safety. J Pract Nurs 36:20-27